SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-007895
Filing Date
2021-01-27
Accepted
2021-01-27 07:00:16
Documents
8
Period of Report
2021-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214248d1_8k.htm 8-K 32671
2 EXHIBIT 4.1 tm214248d1_ex4-1.htm EX-4.1 131790
3 EXHIBIT 10.1 tm214248d1_ex10-1.htm EX-10.1 272083
4 EXHIBIT 10.2 tm214248d1_ex10-2.htm EX-10.2 59489
5 EXHIBIT 10.3 tm214248d1_ex10-3.htm EX-10.3 95435
6 EXHIBIT 10.4 tm214248d1_ex10-4.htm EX-10.4 54284
7 EXHIBIT 99.1 tm214248d1_ex99-1.htm EX-99.1 17117
8 GRAPHIC tm214248d1_ex99-1img001.jpg GRAPHIC 3131
  Complete submission text file 0001104659-21-007895.txt   668768
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 21556706
SIC: 2836 Biological Products, (No Diagnostic Substances)